MAPP BIOPHARMACEUTICAL, INC. SBIR Phase I Award, June 2018
A SBIR Phase I contract was awarded to Mapp Biopharmaceutical Inc in June, 2018 for $298,015.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
298,015
0
Government Branch
Date Awarded
June 29, 2018
0
End Date
May 31, 2020
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R44AI141282-01
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like MAPP BIOPHARMACEUTICAL, INC. SBIR Phase I Award, June 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.